Piling On: AstraZeneca Files Sixth Manufacturer Lawsuit Against Medicare Negotiation Program

Firm leans into allegations that the US government violated the Administrative Procedures Act in implementing the program. More legal actions are expected from industry once CMS announces the first list of drugs subject to negotiation. Our lawsuit tracker will keep you apprised.

Pharma On A Litigation Blitz Against Negotiation Program • Source: Shutterstock

More from Drug Pricing

More from Scrip